Title | | Webcapture | | Abstract | | Speaker |
| Advances in early rectal cancer treatment | | 
| | .jpg) | | Simon P. Bach |
| | | | | | |
| Allogeneic blood stem cell transplantation | |
| |
| | Martin Bornhauser |
| | | | | | | |
| An update of sentinel node biopsy on breast cancer | |
| |
| | Robert E. Mansel |
| | | | | | | |
| Antiemetics - state of the art | |
| |
| | Jørn Herrstedt |
| | | | | | | |
| Beyond the KRAS test | |
| |
| | Pierre Laurent Puig |
| | | | | | | |
| Biology of cancer and aging | |
| |
| | Diana Van Heemst |
| | | | | | | |
| Bisphosphonates for care and cure | |
| |
| | Jean-Jacques Body |
| | | | | | | |
| Cancer and nutrition - key determinants of quality of life | |
| |
| | Paula Ravasco |
| | | | | | | |
Cardiac disease and second lung cancer after radiotherapy for breast cancer | |
| |
| | Candace Correa |
| | | | | | | |
| Cervical cancer and vaccination- an overview | |
| |
| | Elmar Joura |
| | | | | | | |
Current standards and options in the treatment of squamous cell esophageal cancer | |
| |
| | Christophe Mariette |
| | | | | | | |
| Current treatment of high risk testis cancer | |
| |
| | Hans-Joachim Schmoll |
| | | | | | | |
| Desmoid-type fibromatosis: what works best ? | |
| | | | Alessandro Gronchi |
| | | | | | | |
| Epigenetic information in chromatin and cancer | |
| |
| | Zdenko Herceg |
| | | | | | | |
Evidence-based medicine: development and implementation of treatment guidelines in oncology | |
| |
| | Nikolaos Pavlidis |
| | | | | | | |
| How to perform translational research in melanoma | |
| |
| | Alain Spatz |
| | | | | | | |
| How to use functional imaging information for radiotherapy planning | |
| |
| | Vinçent Gregoire |
| | | | | | | |
| HPV and prognosis for patients with oropharynx cancer | |
| |
| | Maura L. Gillison |
| | | | | | | |
IMRT and molecular biological approaches in radiotherapy for prostate cancer | |
| |
| | Robert Bristow |
| | | | | | | |
| Lung cancer screening | |
| |
| | Luis M. Montuenga |
| | | | | | | |
| Lung cancer screening | |
| |
| | Ronald J. Van Klaveren |
| | | | | | | |
| Micro RNA's and their antagonists as novel therapeutics | |
| |
| | Noam Shomron |
| | | | | | | |
Mission accomplished or work in progress - laparoscopic vs open colorectal surgery | |
| |
| | Wolfgang Schwenk |
| | | | | | | |
Neoadjuvant chemotherapy for breast cancers: current recommendations and future directions | |
| |
| | Fabrice Andre |
| | | | | | | |
| New agents for metastatic prostate cancer | |
| |
| | Karim Fizazi |
| | | | | | | |
New approaches to clinical trial design for rare tumours including childhood cancer | |
| |
| | Marie-Cecile Le Deley |
| | | | | | | |
| Particle therapy – physical, technical and clinical aspects | |
| |
| | Juergen Debus |
| | | | | | | |
| Personalised radiotherapy - what is evidence-based? | |
| |
| | Claus Belka |
| | | | | | | |
Pharmacokinetics and pharmacodynamic biomarkers in early oncology drug development | |
| |
| | Chris H. Takimoto |
| | | | | | | |
| Portrait of invasive lobular carcinoma of the breast | |
| |
| | Bernhard C. Pestalozzi |
| | | | | | | |
| PSA screening-review of recent studies | |
| |
| | Fritz H. Schröder |
| | | | | | | |
| Psycho-science: where do we go from here? | |
| |
| | Lesley G. Walker |
| | | | | | | |
| Rare tumours of the chest | |
| |
| | Enriqueta Felip Font |
| | | | | | | |
| Re-irradiation in brain tumours - evidence, indications and limitations | |
| |
| | Susan Short |
| | | | | | | |
| Screening for colorectal cancer, where are we now? | |
| |
| | Nadir Arber |
| | | | | | | |
| Subclassification of ovarian cancer based on pathology and genetics | |
| |
| | Jaime Prat |
| | | | | | | |
| The challenge of interacting with patients in oncology | |
| |
| | Nathan I. Cherny |
| | | | | | | |
| The value of new imaging technology for target volume delineation | |
| |
| | Vincent Khoo |
| | | | | | | |
| Therapy of diffuse large B-cell lymphomas | |
| |
| | Michael Pfreundschuh |
| | | | | | | |
| Treatment of limited disease - small cell lung cancer | | | |
| | Dirk De Ruysscher |
| | | | | | | |
| Value of quality indicators for cancer services | |
| |
| | Ulrich Wagner |